Companies
Multiply Labs
deploys collaborative-robot-driven automation for cell-therapy bio-manufacturing, with a documented 74% cost-reduction case study using Universal Robots cobots, targeting the specific high-touch manual steps within a broader manufacturing line rather than the entire process.
- Country
- United States
US
Coverage
| EU | US | |
|---|---|---|
| automation-robotics | ✓ | ✓ |
Regulatorsfdaema
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Automated cell culture systems | automation-robotics | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.